Billionaire Li's Biotech Firm a Step Closer to Putting New Cancer Drug on Market

Billionaire Li's Biotech Firm a Step Closer to Putting New Cancer Drug on Market


The Hong Kong-based company, known as Chi-Med, said in a statement Friday that it is currently preparing to submit a new drug application for fruquintinib to the China Food and Drug Administration. Chi-Med's shares traded 6 percent higher in London at 8:15 a.m. local time.



from Biotech News